Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

COVID-19 may harm male fertility and damage the reproductive system.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Fetal skin has unique immune cells different from adult skin.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Aged individuals heal wounds less effectively due to specific immune cell issues.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.